Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Lipogene Company Inc
Profile last edited on: 1/29/18      CAGE: 7E7U0      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2015
First Award
2016
Latest Award
2018
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2708 Wilshire Boulevard
Santa Monica, CA 90403
   (310) 459-0163
   N/A
   www.lipogenecompany.com
Location: Single
Congr. District: 33
County: Los Angeles

Public Profile

Lipogene Company, Inc. is a biotechnology company developing non-viral plasmid DNA therapeutics for diseases of the central nervous system. Lipogene is the “non-viral” solution to brain DNA drug delivery. Lipogene’s proprietary pegylated immuno-liposome (PIL) technology enables delivery of non-viral plasmid DNA across the blood-brain barrier following non-invasive intravenous administration without viruses. Currently developing PILs for plasmid DNA drugs, with the PIL platform, Lipogene is addressing development of novel new plasma DNA therapeutic products for many brain diseases for which no existing therapy is now availa

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
2
Conversion Rate
66.67%
Phase I Dollars
$210,836
Phase II Dollars
$2,146,155
Total Awarded
$2,356,991

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2018 1 NIH $210,834
Project Title: Platform Delivery Technology for Plasmid DNA Therapeutics
2018 2 NIH $999,270
Project Title: New Treatment of the Brain in Niemann Pick C
2017 2 NIH $1,146,887
Project Title: Brain DNA Therapeutics with Trojan Horse Liposomes

Key People / Management

  Dahai Jiang

  William M Pardridge

Company News

There are no news available.